reports
Raymond James Financial Reports Fiscal Second Quarter of 2024 Results
Raymond James Financial Reports Fiscal Second Quarter of 2024 Results ST. PETERSBURG, Fla., April 24, 2024 (GLOBE NEWSWIRE) -- Record client assets under administration of $1.45 trillion and record Private Client Group assets in fee-based accounts of $798.8 billion, up 18% and 20%, respectively, over March 2023Record quarterly net revenues of $3.12 billion, up 9% over the prior year’s fiscal second quarter and 3% over the preceding quarterQuarterly net income available to common shareholders of $474 million, or $2.22 per diluted share; quarterly adjusted net income available to comm...
Goosehead Insurance, Inc. Announces First Quarter 2024 Results
Goosehead Insurance, Inc. Announces First Quarter 2024 Results – Total Revenue Increased 11% and Core Revenue Grew 13% over the Prior-Year Period –– Total Written Premium increased 28% to $819 million over the Prior-Year Period –– Net Income of $1.8 million versus Net Loss of $0.2 million a year ago –– Adjusted EBITDA* of $11.7 million versus $10.2 million in the Prior-Year Period –– Company Announces a $100 million Share Repurchase Authorization through March 2025 – WESTLAKE, Texas, April 24, 2024 (GLOBE NEWSWIRE) -- Goosehead Insurance, Inc. (“Goosehead” or the “Company”) (NA...
National Bank Holdings Corporation Announces First Quarter 2024 Financ...
National Bank Holdings Corporation Announces First Quarter 2024 Financial Results DENVER, April 24, 2024 (GLOBE NEWSWIRE) -- National Bank Holdings Corporation (NYSE: NBHC) reported: For the quarter(1) 1Q24 4Q23 1Q23Net income ($000's) $ 31,391 $33,121 $40,283 Earnings per share - diluted $ 0.82 $0.87 $1.06 Return on average assets 1.28% 1.33% 1.70%Return on average tangible assets(2) 1.39% 1.44% 1.80%Return on average equity 10.30% 11.10% 14.60%Return on average tangible common equity(2) 15.14% 16.56% 20.86% ...
ContextLogic to Announce First Quarter 2024 Results on May 8, 2024
ContextLogic to Announce First Quarter 2024 Results on May 8, 2024 Conference Call to be Webcast Live at 5 PM ET / 2 PM PT SAN FRANCISCO, April 24, 2024 (GLOBE NEWSWIRE) -- ContextLogic Inc. (NASDAQ: WISH) today announced it will report its first quarter 2024 financial results after the close of market on Wednesday, May 8, 2024. ContextLogic’s management team will host a live conference call and webcast for shareholders, analysts and portfolio managers to discuss the company’s first quarter results that afternoon at 5:00 PM ET / 2:00 PM PT. Information about the company’s financial r...
John B. Sanfilippo & Son, Inc. 3rd Quarter Fiscal Year 2024 Operating ...
John B. Sanfilippo & Son, Inc. 3rd Quarter Fiscal Year 2024 Operating Results Conference Call Elgin, IL, April 24, 2024 (GLOBE NEWSWIRE) -- John B. Sanfilippo & Son, Inc. (NASDAQ: JBSS), a major processor and distributor of snack and recipe nut products, will hold its quarterly conference call to discuss its third quarter fiscal year 2024 operating results on Thursday, May 2, 2024 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). Third quarter fiscal 2024 results are expected to be released after the market closes on Wednesday, May 1, 2024. To register for the call, please click...
Moody's Ratings: Tapestry's and Capri's ratings unaffected by recent F...
Moody's Ratings (Moody's) commented that the ratings and outlooks of Tapestry, Inc. (Tapestry) and Capri Holdings Limited, the parent of Michael Kors (USA), Inc. (Capri), are unaffected by the announcement that the US Federal Trade Commission is seeking to block Tapestry's pending acquisition of Cap...
Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Resu...
Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024 ROCKVILLE, Md., April 24, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that it expects to report financial and business results for the first quarter of 2024 after the market closes on Wednesday, May 8, 2024. Jack Khattar, President and CEO, and Tim Dec, Senior Vice President and CFO, will host a ...
NextNav Announces Date for First Quarter 2024 Earnings Call
NextNav Announces Date for First Quarter 2024 Earnings Call MCLEAN, Va., April 24, 2024 (GLOBE NEWSWIRE) -- NextNav (Nasdaq: NN), a leader in next generation positioning, navigation, timing (PNT) and 3D geolocation, today announced that it will release its financial results for the first quarter ended March 31, 2024, after the market closes on Wednesday, May 8, 2024, and will host a conference call the same day at 5:00 PM ET to discuss its results. Registration for the conference call can be completed by visiting the following website prior to, or on the day of, the conference call: . ...
Orion Group Holdings Reports First Quarter 2024 Results
Orion Group Holdings Reports First Quarter 2024 Results HOUSTON, April 24, 2024 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN) (the “Company”), a leading specialty construction company, today reported its financial results for the first quarter ended March 31, 2024. Highlights for the quarter ended March 31, 2024: Contract revenues of $160.7 millionGAAP net loss was $6.1 million or $0.19 per diluted shareAdjusted net loss was $4.0 million or $0.12 per diluted shareAdjusted EBITDA was $4.1 millionBacklog and contracts awarded subsequent to quarter end totaled $857 million S...
TScan Therapeutics Announces Upcoming Presentations at the 2024 Americ...
TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Meeting WALTHAM, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered T cell therapies (TCR-T) for the treatment of patients with cancer, today announced the acceptance of two abstracts for poster presentation at the upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting being held May 31 – June 4 in Chicago, IL as well as virtu...
Brookline Bancorp Announces First Quarter Results
Brookline Bancorp Announces First Quarter Results Net Income of $14.7 million, EPS of $0.16 Quarterly Dividend of $0.135 BOSTON, April 24, 2024 (GLOBE NEWSWIRE) -- Brookline Bancorp, Inc. (NASDAQ: BRKL) (the “Company”) today announced net income of $14.7 million, or $0.16 per basic and diluted share, for the first quarter of 2024, compared to net income of $22.9 million, or $0.26 per basic and diluted share, for the fourth quarter of 2023, and net income of $7.6 million, or $0.09 per basic and diluted share, for the first quarter of 2023. Paul Perrault, Chairman and CEO, commented on t...
Amplify Energy Schedules First Quarter 2024 Earnings Release and Confe...
Amplify Energy Schedules First Quarter 2024 Earnings Release and Conference Call HOUSTON, April 24, 2024 (GLOBE NEWSWIRE) -- Amplify Energy Corp. (“Amplify” or the “Company”) (NYSE: AMPY) announced today that it will report first quarter 2024 financial and operating results after the U.S. financial markets close on May 8, 2024. Management will host a conference call at 10:00 a.m. CT on May 9, 2024 to discuss the Company’s results. Interested parties are invited to participate in the conference call by dialing (800) 901-2707 (Conference ID: AEC1Q24) at least 15 minutes prior to the start o...
Corcept Therapeutics to Announce First Quarter Financial Results, Prov...
Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call MENLO PARK, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report first quarter financial results and provide a corporate update on May 1, 2024. The company will also host a conference call that day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). Conference Call Information Participants must register in advance of the conference call by clicking Upon registering, each participant will receive a dial-...
Erasca Announces Three Presentations at the 2024 ASCO Annual Meeting
Erasca Announces Three Presentations at the 2024 ASCO Annual Meeting Oral presentation will feature updated HERKULES-3 results for ERK1/2 inhibitor ERAS-007 in combination with encorafenib and cetuximab in BRAFm colorectal cancer Poster presentations will feature SEACRAFT-1 Phase 1 trial design for naporafenib plus trametinib in RAS Q61X mutations, and preliminary FLAGSHP-1 Phase 1 results for ERAS-601 and cetuximab in chordoma SAN DIEGO, April 24, 2024 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, develop...
Cardlytics Announces Timing of Its First Quarter 2024 Earnings Release
Cardlytics Announces Timing of Its First Quarter 2024 Earnings Release ATLANTA, April 24, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: CDLX), an advertising platform in banks’ digital channels, today announced that its first quarter ended March 31, 2024 financial results will be released on May 8, 2024, after market close. The results will be discussed via conference call at 5:00 PM (ET) / 2:00 PM (PT). The company invites investors to join a live audio webcast at or to dial-in by registering . A replay will be available on the Cardlytics Investor Relations website at . About Cardlytics Cardlyti...
Covenant Logistics Group Announces First Quarter Financial and Operati...
Covenant Logistics Group Announces First Quarter Financial and Operating Results CHATTANOOGA, Tenn., April 24, 2024 (GLOBE NEWSWIRE) -- Covenant Logistics Group, Inc. (NASDAQ/GS: CVLG) (“Covenant” or the “Company”) announced today financial and operating results for the first quarter ended March 31, 2024. The Company’s conference call to discuss the quarter will be held at 10:00 A.M. Eastern Time on Thursday, April 25, 2024. Chairman and Chief Executive Officer, David R. Parker, commented: “We are pleased to report first quarter earnings of $0.29 per diluted share and non-GAAP adju...
JAKKS Pacific Reports First Quarter 2024 Financial Results
JAKKS Pacific Reports First Quarter 2024 Financial Results Preferred Share Retirement Completed SANTA MONICA, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- JAKKS Pacific, Inc. (NASDAQ: JAKK) today reported financial results for the first quarter ended March 31, 2024. First Quarter 2024 Net sales were $90.1 million, a year-over-year decrease of $17.4 million or 16%, driven by a lack of new film releases vs. prior yearGross margin of 23.4%, down 580 basis points vs. Q1 2023, led by higher inventory obsolescence expense, and retailer markdownsGross profit of $21.1 million, down $10.4 mi...
Essential Properties Announces First Quarter 2024 Results
PRINCETON, N.J.--(BUSINESS WIRE)-- Essential Properties Realty Trust, Inc. (NYSE: EPRT; “Essential Properties” or the “Company”) today announced operating results for the three months ended March 31, 2024. First Quarter 2024 Financial and Operating Highlights: Operating Results (compared to First Quarter 2023): • Investments (79 properties) $ Invested $248.8 million Weighted Avg Cash Cap Rate 8.1% • Dispositions (7 properties) Net Proceeds $11.9 million Weighted Avg Cash Cap Rate 6.5% ...
AMERISAFE Announces 2024 First Quarter Results
DERIDDER, La.--(BUSINESS WIRE)-- AMERISAFE, Inc. (Nasdaq: AMSF), a specialty provider of workers’ compensation insurance focused on high-hazard industries, today announced results for the first quarter ended March 31, 2024. Three Months Ended March 31, 2024 2023 % Change (in thousands, except per share data) Net premiums earned $ 68,446 $ 69,181 -1.1 % Net investment income 7,366 7,433 -0.9 % ...
Predictive Oncology Announces Abstract Accepted for Presentation at th...
Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting PITTSBURGH, April 24, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, today announced that an abstract has been accepted for presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, which is being held May 31-June 4, 2024, in Chicago, Il. The abstract highlights results from a recent study that Predictive Oncology completed in collaboration with UPMC Magee...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.